| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
An imbalance between estrogen action relative to androgen action at the breast tissue level results in gynecomastia. Enhancement of aromatization of androgens to estrogens is important in the pathogenesis of gynecomastia associated with obesity, aging, puberty, liver disease, thyrotoxicosis, 17-oxosteroid reductase deficiency. Klinefelter's syndrome, and neoplasms of the testes, adrenals and liver. A primary aromatase excess syndrome with exuberant gynecomastia had been found both sporadically and in a familial setting. Although aromatase inhibition would appear to be an important class of drugs to treat gynecomastia, relatively little published data with these drugs exist and most concern the use of delta1-testolactone, which reduces the size of the breast glandular tissue, but does not completely ameliorate the problem. Studies with the newer generation of more potent aromatase inhibitors need to be carried out.
This article has been cited by other articles:
|
|
 |
|
  I. Czajka-Oraniec, W. Zgliczynski, A. Kurylowicz, M. Mikula, and J. Ostrowski Association between gynecomastia and aromatase (CYP19) polymorphisms Eur. J. Endocrinol., May 1, 2008; 158(5): 721 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Braunstein Gynecomastia N. Engl. J. Med., September 20, 2007; 357(12): 1229 - 1237. [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, L. Strauss, S. Makela, T. Streng, I. Huhtaniemi, R. Santti, and M. Poutanen Multiple Structural and Functional Abnormalities in the P450 Aromatase Expressing Transgenic Male Mice Are Ameliorated by a P450 Aromatase Inhibitor Am. J. Pathol., March 1, 2004; 164(3): 1039 - 1048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rivas, C. Mckinnell, J. S. Fisher, N. Atanassova, K. Williams, and R. M. Sharpe Neonatal Coadministration of Testosterone With Diethylstilbestrol Prevents Diethylstilbestrol Induction of Most Reproductive Tract Abnormalities in Male Rats J Androl, July 1, 2003; 24(4): 557 - 567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Rivas, J. S. Fisher, C. McKinnell, N. Atanassova, and R. M. Sharpe Induction of Reproductive Tract Developmental Abnormalities in the Male Rat by Lowering Androgen Production or Action in Combination with a Low Dose of Diethylstilbestrol: Evidence for Importance of the Androgen-Estrogen Balance Endocrinology, December 1, 2002; 143(12): 4797 - 4808. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, A. Warri, S. Makela, T. Ahonen, T. Streng, R. Santti, and M. Poutanen Mammary Gland Development in Transgenic Male Mice Expressing Human P450 Aromatase Endocrinology, October 1, 2002; 143(10): 4074 - 4083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ueyama, N. Shirasawa, M. Numazawa, K. Yamada, M. Shelangouski, T. Ito, and Y. Tsuruo Gastric Parietal Cells: Potent Endocrine Role in Secreting Estrogen as a Possible Regulator of Gastro-Hepatic Axis Endocrinology, August 1, 2002; 143(8): 3162 - 3170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Santen To Block Estrogen's Synthesis or Action: That Is the Question J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3007 - 3012. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Conley, S. Mapes, C. J. Corbin, D. Greger, and S. Graham Structural Determinants of Aromatase Cytochrome P450 Inhibition in Substrate Recognition Site-1 Mol. Endocrinol., July 1, 2002; 16(7): 1456 - 1468. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
